{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:35:20Z","timestamp":1790091320821,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1007\/s11864-003-0039-2","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T21:23:29Z","timestamp":1183584209000},"page":"385-390","source":"Crossref","is-referenced-by-count":250,"title":["Metastatic renal cell carcinoma"],"prefix":"10.1007","volume":"4","author":[{"given":"Robert C.","family":"Flanigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph I.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Picken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"39_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","volume":"50","author":"RA Greenlee","year":"2000","unstructured":"Greenlee RA, Murray T, Bolden S, et al.: Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"39_CR2","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1001\/jama.281.17.1628","volume":"281","author":"W Chow","year":"1999","unstructured":"Chow W, Devesa S, Warren J, Fraumeri J: Rising incidence of renal cell cancer in the United States. JAMA 1999, 281:1628\u20131631. The rising incidence of RCC in the United States is provocative. Based on current data, this increase seems to be occurring in local and distant disease.","journal-title":"JAMA"},{"key":"39_CR3","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/1097-0142(1971)28:5<1165::AID-CNCR2820280513>3.0.CO;2-G","volume":"28","author":"DG Skinner","year":"1971","unstructured":"Skinner DG, Colvin RV, Vermillion CD, et al.: Diagnosis and management of renal cell carcinoma: a clinical and pathological study of 309 cases. Cancer 1971, 28:1165\u20131177.","journal-title":"Cancer"},{"key":"39_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ajmg.10697","volume":"115","author":"AM Meloni-Ehrig","year":"2002","unstructured":"Meloni-Ehrig AM: Renal cancer: cytogenetic and molecular genetic aspects. Am J Med Genet 2002, 115:164\u2013172.","journal-title":"Am J Med Genet"},{"key":"39_CR5","first-page":"3","volume":"22","author":"JR Gnarra","year":"1995","unstructured":"Gnarra JR, Lerman MI, Zbar B, Linehan WM: Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin Oncol 1995, 22:3\u20138.","journal-title":"Semin Oncol"},{"key":"39_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jama.273.7.564","volume":"273","author":"WM Linehan","year":"1995","unstructured":"Linehan WM, Lerman MI, Zbar B: Identification of the von Hippel-Lindau (VHL) gene: its role in renal cancer. JAMA 1995, 273:564\u2013570. This hallmark paper discusses the VHL gene and its implication in VHL diseases and sporadic RCC.","journal-title":"JAMA"},{"key":"39_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ki.1997.82","volume":"51","author":"AP Levy","year":"1997","unstructured":"Levy AP, Levy NS, Iliopoulos O, et al.: Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene. Kidney Int 1997, 51:575\u2013578.","journal-title":"Kidney Int"},{"key":"39_CR8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0094-0143(21)00484-5","volume":"2","author":"JB Thrasher","year":"1993","unstructured":"Thrasher JB, Paulson DF: Prognostic factors in renal cancer. Urol Clin North Am 1993, 2:247\u2013262.","journal-title":"Urol Clin North Am"},{"key":"39_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-5347(17)43859-6","volume":"137","author":"JA Libertino","year":"1987","unstructured":"Libertino JA, Zinman L, Watkins E Jr: Long-term results of resection of renal cell cancer with extension into inferior vena cava. J Urol 1987, 137:21\u201324.","journal-title":"J Urol"},{"key":"39_CR10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0022-5347(17)47235-1","volume":"134","author":"B Bassil","year":"1985","unstructured":"Bassil B, Dosoretz DE, Prout GR Jr: Validation of the tumor, nodes, and metastasis classification of renal cell carcinoma. J Urol 1985, 134:450\u2013454.","journal-title":"J Urol"},{"key":"39_CR11","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMoa003013","volume":"345","author":"RC Flanigan","year":"2001","unstructured":"Flanigan RC, Salmon SE, Blumenstein BA, et al.: Nephrectomy followed by interferon alfa-2b compared to interferon alfa-2b alone for metastatic renal cell cancer. N Engl J Med 2001, 345:1655\u20131659. This paper represents the first prospective randomized trial demonstrating the role of cytoreductive nephrectomy in metastatic RCC. The outcomes are stratified by pretreatment stratification variables.","journal-title":"N Engl J Med"},{"key":"39_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","volume":"6","author":"SA Fuhrman","year":"1982","unstructured":"Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6:655\u2013663.","journal-title":"Am J Surg Pathol"},{"key":"39_CR13","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1200\/JCO.2002.05.111","volume":"20","author":"A Zisman","year":"2002","unstructured":"Zisman A, Pantuck AJ, Wieder J, et al.: Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002, 20:4559\u20134566. Based on the extensive experience at UCLA (Los Angeles, CA) with RCC, the authors have developed a useful schema for the prediction of outcomes.","journal-title":"J Clin Oncol"},{"key":"39_CR14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0022-5347(05)67889-5","volume":"163","author":"R Motzer","year":"2000","unstructured":"Motzer R, Russon P: Systemic therapy for renal cell carcinoma. J Urol 2000, 163:408\u2013417.","journal-title":"J Urol"},{"key":"39_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-5347(17)66934-9","volume":"114","author":"DE Johnson","year":"1975","unstructured":"Johnson DE, Kaesler KE, Samuels ML: Is nephrectomy justified in patients with metastatic renal carcinoma?\n                           J Urol 1975, 114:27\u201329.","journal-title":"J Urol"},{"key":"39_CR16","first-page":"7310","volume":"48","author":"PR Elson","year":"1988","unstructured":"Elson PR, Witte RS, Trump DL: Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 1988, 48:7310\u20137313.","journal-title":"Cancer Res"},{"key":"39_CR17","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199804303381805","volume":"338","author":"S Negrier","year":"1998","unstructured":"Negrier S, Escudier B, Lasset C, et al.: Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal cell carcinoma. N Engl J Med 1998, 338:1272\u20131278.","journal-title":"N Engl J Med"},{"key":"39_CR18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0094-0143(21)00485-7","volume":"20","author":"DR Couillard","year":"1993","unstructured":"Couillard DR, DeVere White RW: Surgery of renal cell carcinoma. Urol Clin North Am 1993, 20:263\u2013275.","journal-title":"Urol Clin North Am"},{"key":"39_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0090-4295(77)90303-X","volume":"6","author":"S Freed","year":"1977","unstructured":"Freed S: Nephrectomy for renal cell carcinoma with metastases. Urology 1977, 6:613\u2013616.","journal-title":"Urology"},{"key":"39_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/0090-4295(93)90612-E","volume":"42","author":"MM Walther","year":"1993","unstructured":"Walther MM, Alexander RB, Weiss GH: Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma. Urology 1993, 42:250\u2013257.","journal-title":"Urology"},{"key":"39_CR21","first-page":"641","volume":"100","author":"JB DeKernion","year":"1982","unstructured":"DeKernion JB, Lindner A: Treatment of advanced renal cell carcinoma. Prog Clin Biol Res 1982, 100:641\u2013659.","journal-title":"Prog Clin Biol Res"},{"key":"39_CR22","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1200\/JCO.1998.16.6.2261","volume":"16","author":"DP Kavolius","year":"1998","unstructured":"Kavolius DP, Mastorakos C, Pavlovich P, et al.: Resection of metastatic renal cell carcinoma. J Clin Oncol 1998, 16:2261\u20132266.","journal-title":"J Clin Oncol"},{"key":"39_CR23","first-page":"227","volume":"350","author":"A Yagoda","year":"1990","unstructured":"Yagoda A: Phase II cytotoxic chemotherapy trials in RCC: 1983-1988. Prog Clin Biol Res 1990, 350:227\u2013241.","journal-title":"Prog Clin Biol Res"},{"key":"39_CR24","doi-asserted-by":"publisher","first-page":"381a","DOI":"10.1016\/S0022-5347(01)61897-4","volume":"161","author":"RA Figlin","year":"1999","unstructured":"Figlin RA: Renal cell carcinoma: management of advanced disease [abstract]. J Urol 1999, 161:381a.","journal-title":"J Urol"},{"key":"39_CR25","first-page":"237","volume":"14","author":"BJ Gitlitz","year":"1996","unstructured":"Gitlitz BJ, Belldegrun A, Figlin R: Immunotherapy and gene therapy. Semin Urol Oncol 1996, 14:237\u2013243.","journal-title":"Semin Urol Oncol"},{"key":"39_CR26","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1198::AID-CNCR3>3.0.CO;2-H","volume":"80","author":"RM Bukowski","year":"1997","unstructured":"Bukowski RM: Natural history and therapy of metastatic renal cell carcinoma. Cancer 1997, 80:1198\u20131220.","journal-title":"Cancer"},{"key":"39_CR27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-5347(17)37124-0","volume":"147","author":"WF Spencer","year":"1992","unstructured":"Spencer WF, Linehan WM, Walther MM, et al.: Immunotherapy with interleukin-2 and interferon in patients with metastatic renal cell cancer in situ primary cancers: a pilot study. J Urol 1992, 147:24\u201330.","journal-title":"J Urol"},{"key":"39_CR28","first-page":"227","volume":"14","author":"RC Flanigan","year":"1996","unstructured":"Flanigan RC: Role of surgery in patients with metastatic renal cell carcinoma. Semin Urol Oncol 1996, 14:227\u2013229.","journal-title":"Semin Urol Oncol"},{"key":"39_CR29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1200\/JCO.1995.13.3.688","volume":"13","author":"G Fyfe","year":"1995","unstructured":"Fyfe G, Fisher RI, Rosenberg SA, et al.: Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol 1995, 13:688\u2013696.","journal-title":"J Clin Oncol"},{"key":"39_CR30","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1200\/JCO.2002.11.123","volume":"20","author":"RJ Motzer","year":"2002","unstructured":"Motzer RJ, Bacik J, Mariani T, et al.: Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear cell histology. J Clin Oncol 2002, 20:2376\u20132381. This interesting manuscript describes the behavior of nonclear cell RCC. This is valuable information in the era of increased appreciation of the various types of RCC and their individual characteristics.","journal-title":"J Clin Oncol"},{"key":"39_CR31","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S0140-6736(01)06103-7","volume":"358","author":"GH Mickisch","year":"2001","unstructured":"Mickisch GH, Garin A, van Poppel H, et al.: Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal cell carcinoma. Lancet 2001, 358:966\u2013970. This prospective randomized trial of cytoreductive nephrectomy was done by the European Organization for Research and Treatment of Cancer and uses the SWOG protocol [15]. It provides additional useful support of the concept of cytoreductive nephrectomy.","journal-title":"Lancet"},{"key":"39_CR32","unstructured":"van Veldhuizen PJ, Faulkner JR, Lara PN, et al.: A phase II study of flavopiridol (Flavo) in patients with advanced renal cell cancer: results of Southwest Oncology Group trial S0109 [abstract].\n                           Am Soc Clin Oncol 2003:1552a."},{"key":"39_CR33","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1056\/NEJM200009143431101","volume":"343","author":"R Childs","year":"2000","unstructured":"Childs R, Chernoff A, Contentin N, et al.: Regression of metastatic renal cell carcinoma after nonmyeloablative allogenic peripheral blood stem cell transplantation. N Engl J Med 2000, 343:750\u2013758. Miniallotransplantation provides a new and interesting look at the biologic behavior of metastatic RCC and a useful technique for patients with this disease. The toxicity and early success of this concept is discussed.","journal-title":"N Engl J Med"},{"key":"39_CR34","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1464-410X.1997.00140.x","volume":"79","author":"M Nakagawa","year":"1997","unstructured":"Nakagawa M, Emoto A, Hanada T, et al.: Tubulogenesis by microvascular endothelial cells is mediated by vascular endothelial growth factor (VEGF) in renal cell carcinoma. Br J Urol 1997, 79:681\u2013687.","journal-title":"Br J Urol"},{"key":"39_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0165-4608(00)00375-7","volume":"125","author":"Kadam PS Amare","year":"2001","unstructured":"Amare Kadam PS, Varghese C, Bharde SH, et al.: Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7. Cancer Genet Cytogenet 2001, 125:139\u2013146.","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-003-0039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-003-0039-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-003-0039-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-003-0039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T14:10:37Z","timestamp":1652623837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-003-0039-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s11864-003-0039-2","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}